Regjeringen (via Public) / A Broader Basis for Making Decisions concerning Viral Vector Vaccines
A Broader Basis for Making Decisions concerning Viral Vector Vaccines The final decision concerning the use of the AstraZeneca and Janssen COVID-19 vaccines will be taken by the Norwegian Government. A committee of experts, both foreign and national, will be appointed to examine the consequences of using or not using these vaccines in the vaccination programme. The Norwegian Institute of Public Health recommends removing the AstraZeneca vaccine from the vaccination programme permanently due to the risk of rare but severe side effects. The Norwegian Institute of Public Health has assessed this...
Source: publicnow.com